The Claim
The combination of phenformin and dichloroacetate increases oxidative stress and DNA damage markers (γ-H2AX, p-CHK2) and reduces p-BRCA1 expression, impairing homologous recombination repair in DIPG cells.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The drugs phenformin and dichloroacetate together increase markers of DNA damage and reduce a key repair protein in DIPG brain cancer cells, leading to impaired DNA repair.
See the scientific wording
The phenformin and dichloroacetate combination increases oxidative stress and DNA damage markers (γ-H2AX, p-CHK2) and impairs homologous recombination repair (reduced p-BRCA1) in DIPG cells, suggesting a mechanism for enhanced radiosensitization.
Two drugs together stop cancer cells from making energy in two different ways, causing a buildup of harmful molecules that break DNA and simultaneously block the cell's ability to fix those breaks, making radiation more effective at killing the cells.
What the research says
1 studyIn lab tests, mixing two drugs (phenformin and DCA) made brain tumor cells more vulnerable to radiation by damaging their DNA and stopping them from fixing it. This made the radiation work better at killing the cancer cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.